EC Healthcare has issued a profit warning, advising that the company's earnings before interest, taxes, depreciation, and amortization (EBITDA) for the fiscal year ending 31 March 2025 (FY2025) are expected to be between HK$300 million and HK$310 million. This represents a decrease from the HK$388.1 million reported for FY2024. The announcement is based on the preliminary unaudited consolidated management accounts of the Group. The company cautions shareholders and potential investors that the figures are subject to change as the results for FY2025 have not been finalized, reviewed, or audited. The final results are expected to be published on 19 June 2025. EC Healthcare advises exercising caution when dealing with its shares, as the overall performance of the Group during FY2025 could be influenced by various factors.